Respiratory

Latest News

Nerandomilast is an investigational oral, preferential inhibitor of phosphodiesterase 4B that has shown promise in IPF and PPF. | Image credit: Елена Бутусова - stock.adobe.com
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

February 13th 2025

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.

Sanofi | Image credit: Eagle - stock.adobe.com
Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

December 16th 2024

Group of diverse kids | Image Credit: © EKKAPON-stock.adobe.com
Ambient Toxins Linked to Disabilities in Minority Schoolchildren

December 10th 2024

RSV vaccine | Image credit: Pawel - atock.adobe.com
Nirsevimab Protected Infants, Children From Severe RSV in 2023–2024 Season

December 6th 2024

Doctor with an image of lungs | Image credit: lungs_PRASANNAPIX
Key Flu and RSV Recommendations for the 2024-2025 Respiratory Virus Season

November 26th 2024

Continuing Medical Education
View All
March 18th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

teen girl vaping
April 20th 2022

Review Highlights Need for Stricter Health Policies Amid Rising e-Cigarette Use

Hayden E. Klein
According to a review, the availability of electronic cigarettes and vaping products to young people needs to be limited.
Roxana Siles, MD, FAAAAI, Cleveland Clinic
April 20th 2022

Dr Roxana Siles Discusses Chronic Cough Treatment and Its Adverse Effects

Maggie L. Shaw
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the challenges of treating chronic cough.
Man coughing
April 14th 2022

Chronic Cough Linked to Disproportionate Depressive Symptoms, Study Finds

Hayden E. Klein
For adults with a history of depression, chronic cough can increase the risk of recurrent depressive events, a study found.
Roxana Siles, MD, FAAAAI, Cleveland Clinic
April 12th 2022

Dr Roxana Siles: Multispecialty Management of Chronic Cough Maximizes Patient Benefits

Maggie L. Shaw
Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the factors that contribute to necessitating multispecialty management of patients with chronic cough.
tree in the shape of a lung
April 9th 2022

Pollutant Particle Size Affects Deposition in the Lung, Study Finds

Hayden E. Klein
Pollutant particles with a smaller diameter, density, and flow rate can enter the deep lung, but large particles with a low density may also enter the deep airways, according to a study.
Patsy Stinchfield, RN, MS, and William Schaffner, MD
April 2nd 2022

NFID Board Members Discuss Solutions to RSV-Related Disparities

Hayden E. Klein
William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss health care disparities related to respiratory syncytial virus (RSV), as well as solutions to close these gaps.
doctor with checklist
April 1st 2022

Researchers Develop 51-Item Framework for Cough Severity Measurement

Hayden E. Klein
Urge-to-cough and cough symptoms were the 2 main domains of a 51-item framework to measure cough severity.
child with fever and cough
March 25th 2022

Record High Pediatric Parainfluenza Virus Incidence in Finland

Hayden E. Klein
Monthly parainfluenza virus incidence rates were nearly 6 times higher in September 2021 vs the second highest reported monthly incidence rates among children 4 years and younger in Finland in the last decade, following lifting of COVID-19–related restrictions.
Roxana Siles, MD, FAAAAI, Cleveland Clinic
March 23rd 2022

Dr Roxana Siles Discusses the Complexity of Managing Patients With Chronic Cough

Maggie L. Shaw
Roxana Siles, MD, FAAAAI, codirector of the Asthma Center at Cleveland Clinic, discusses the challenges of managing patients with chronic cough.
William Schaffner, MD, and Patsy Stinchfield, RN, MS, CPNP
March 19th 2022

NFID Board Members: We Need More Accessible, Less Expensive RSV Testing

Hayden E. Klein
William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain how COVID-19 testing developments have opened doors for developments in respiratory syncytial virus (RSV) testing.
Lungs
March 14th 2022

Study Finds Electronic Clinical Decision Support Tool Improves Mortality in Patients With Pneumonia

Julia Bonavitacola
A recent study found that an electronic tool that guides diagnosis and treatment can reduce mortality and improve processes of care.
Hospital hallway
March 11th 2022

Study Finds Better Outcomes When Patients Admitted With ARF Have Quick Inter-ICU Transfers

Julia Bonavitacola
A retrospective, quasi-experimental study found that patients admitted to the intensive care unit (ICU) for acute respiratory failure (ARF) saw better outcomes when an inter-ICU transfer came within the first 2 days of admittance.
baby receiving vaccine
March 2nd 2022

Nirsevimab Protects Late-Preterm, Term Infants From RSV-Related Lower RTI, Study Finds

Hayden E. Klein
A phase 3 trial showed that nirsevimab was effective in preventing respiratory syncytial virus (RSV)-associated lower respiratory tract infection in healthy late-preterm and term infants.
Newspapers.
February 28th 2022

What We're Reading: CDC Mask Guidance Loosened; RSV Vaccine Trial Halted; US Transplant System Reform

AJMC Staff
New CDC guidance says that Americans who live in areas with low to medium COVID-19 transmission can stop wearing masks indoors; GlaxoSmithKline (GSK) halts 3 vaccine clinical trials for the respiratory syncytial virus in pregnant women; a scientific advisory panel recommends a major overhaul of the US transplant system.
Patsy Stinchfield, RN, MS, CPNP, and William Schaffner, MD
February 27th 2022

NFID Board Members on How RSV Affects Different Age Groups

Hayden E. Klein
William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss how respiratory syncytial virus (RSV) affects different age groups.
US stethoscope
February 24th 2022

AMA President Reflects on Lessons Learned, Future Challenges After 2 Years of COVID-19

Gianna Melillo
In this National Press Club address, American Medical Association President Gerald E Harmon, MD, outlines what steps need to be taken to better prepare the nation for the next pandemic.
x-ray and stethoscope
February 23rd 2022

Transesophageal Echocardiography Not Linked With Respiratory Failure, Study Finds

Hayden E. Klein
The 28-day cumulative risk of respiratory failure after transesophageal echocardiography (TEE) was similar to the risk measured in those go did not undergo TEE, a procedure performed after a transient ischemic attack or stroke.
lung graphic
February 20th 2022

Small Study Shows 100% Success in Lung Transplants for COVID-19–Associated ARDS

Hayden E. Klein
Survival was 100% among patients who had COVID-19-associated acute respiratory distress syndrome (ARDS), and 83% for those without COVID-19 infection.
Patsy Stinchfield, RN, MS, and William Schaffner, MD
February 16th 2022

NFID Board Members Discuss COVID-19's Impact on RSV Seasonality

Hayden E. Klein
William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain how the COVID-19 pandemic has had an impact on the seasonality of respiratory syncytial virus (RSV).
Doctor holding baby
February 14th 2022

Shorter Treatment for Community-Acquired Pneumonia as Effective as Longer Course

Hayden E. Klein
Research suggests a shorter 5-day antibiotic regimen for childhood community-acquired pneumonia, instead of 10 days, can optimize treatment efficacy while reducing unnecessary antibiotic use.
Nurse and patient walking in hospital hallway
February 5th 2022

Study Finds Higher In-Hospital Mortality Risk for Older Patients With Frailty, COVID-19

Hayden E. Klein
Research showed that younger and nonfrail patients with COVID-19 were more likely to be put on a ventilator, while patients with frailty and older age had a higher risk of in-hospital and in-ICU mortality.
coronavirus
February 4th 2022

Controversial Paper Claims COVID-19 "Lockdowns" Had Little Public Health Effect

Laura Joszt, MA
A meta-analysis from 3 economists concluded that nonpharmaceutical interventions in response to COVID-19 failed to have a large, significant effect on mortality rates.
Site Logo
February 3rd 2022

Antibiotic Practice Patterns With Procalcitonin Levels in Patients With Acute Lower Respiratory Tract Infection

Jessica K. Costales-Cantrell, DO, MBS Joanie Chung, MPH Jim H. Nomura, MD Kristen R. Ironside, MS Paul W. Salama, MD John J. Sim, MD
Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with regularity and also prioritize clinical judgment over PCT results.
What We're Reading
February 2nd 2022

What We’re Reading: Cancer Moonshot Returns; New Omicron Subvariant; Drug Overdose Suicide Rates

AJMC Staff
President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.
Doctor looking at lung radiography
January 27th 2022

Review Evaluates Factors of Pulmonary Disease Subtype Development

Hayden E. Klein
The review discussed the roles of sex, ancestry, senescence, and aging in the development of nontuberculous mycobacterial pulmonary disease.
What We're Reading
January 26th 2022

What We’re Reading: Long-term COVID-19 Factors; Rhode Island Joins Opioid Settlement Case; EPA and "Cancer Alley"

AJMC Staff
A study found 4 factors may correlate with increased risk of long-term COVID-19; Rhode Island joins opioid settlement against McKesson, AmerisourceBergen, and Cardinal Health; the Environmental Protection Agency announced it will station mobile equipment in Louisiana to measure air pollution.
What we're reading stock photo.
January 25th 2022

What We're Reading: Ineffective COVID-19 Drugs; Panel Advises Fourth Dose in Israel; Physician Mental Health Amid Pandemic

AJMC Staff
FDA significantly restricts the use of 2 COVID-19 monoclonal antibody treatments ineffective against the Omicron variant; an expert panel advises the Israeli government to offer a fourth COVID-19 vaccine dose to adults; there was a substantial increase in visits for mental health and substance abuse among physicians with no prior history during the pandemic.
older woman receiving vaccination
January 19th 2022

Study Highlights Health, Economic Benefits of RSV Vaccine for Older Adults

Hayden E. Klein
With no existing respiratory syncytial virus (RSV) vaccine yet, researchers found that a vaccine comparable with the influenza vaccine could prevent tens of thousands of hospitalizations and deaths per year.
Image of senior woman in hospital
January 14th 2022

UK Study Characterizes Patient, Health Care System Burden From Chronic Cough

Rose McNulty
Chronic cough can have a significant impact on patient quality of life, and recognizing it as an individual condition may help optimize its treatment.
COVID-19 graphic
January 7th 2022

CDC Clarifies New COVID-19 Isolation Protocol, Outlines Efforts to Protect Children

Gianna Melillo
CDC officials clarified the agency's new isolation recommendations for individuals infected with COVID-19 and provided updates on its efforts to reduce pediatric cases among those too young to receive vaccines.
<12345678910
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo